Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled (Unreturned Annual)
Current status date:
2018-03-28
Original market date: See footnote 1
Product name:
NU-MEDROXY
DIN:
02252740
Product Monograph/Veterinary Labelling:
Date:
2004-04-20
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
NU-PHARM INC
1165 Creditstone Rd, Unit 2
Vaughan
Ontario
Canada
L4K 4N7
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
68:32.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
G03DA02 MEDROXYPROGESTERONE
Active ingredient group (AIG) number:See footnote5
0106339004
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| MEDROXYPROGESTERONE ACETATE | 2.5 MG |